Expanded virtual outreach draws diverse Class of 2026

In its third application cycle shaped by COVID-19, Cornell has attracted record interest, admitting a talented, diverse Class of 2026 from a broader range of places than ever before.

Study Away helped Cornell students forge, keep connections

Study Away, a residential option created by Global Cornell for international students who could not travel to campus, has helped many fight isolation and build a sense of belonging at Cornell.

Boosters highly effective against COVID hospitalization, death

Booster doses of mRNA vaccines provided strong protection against hospitalization and death from COVID-19 in Qatar, according to a study by investigators at Weill Cornell Medicine – Qatar.

Pandemic prompted exodus from New York City, gains upstate

An analysis of newly released census data by the Cornell Program on Applied Demographics shows how the pandemic’s onset influenced populations in each New York state county.

Delayed consciousness is common for COVID patients on respirators

Most patients with severe COVID who are put on ventilators regain consciousness after removal of respiratory support, but recovery may take weeks after the period of mechanical ventilation has ended, according to a new study.

Pfizer executive describes making the impossible, possible

Pfizer Group President Angela Hwang MBA '94 and Cornell University President Martha E. Pollack discussed Hwang's leadership and Pfizer’s journey to help combat COVID-19 at the 2022 Hatfield lecture.

Cornell to ease mask requirements March 14

Administrators announced that Cornell is initiating a phased approach to relaxing mask requirements, effective March 14.

ILR School tracks scope of 2021 US labor unrest

When the ILR Labor Action Tracker kicked off in early 2021, no one anticipated the pace of workplace activism that ensued. Findings include about 265 actions, such as strikes, with more actions in the South than elsewhere.

$9.8M NIH Grant drives clinical research into long COVID

Weill Cornell Medicine has been awarded a $9.8 million grant from the National Institutes of Health to lead a consortium of health care institutions that are analyzing nationwide health data in an effort to unravel the complexities of long COVID.